QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19

QT-Logs : a Clinical Study to Monitor Cardiac Safety, With Artificial Intelligence for QT Interval Analysis of ECG Data From Smartwatches, in Patients Receiving Hydroxychloroquine Treatment for COVID-19

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04371744

Acronym

QT-Logs

Enrollment

100

Registered

2020-05-01

Start date

2020-04-17

Completion date

2020-06-05

Last updated

2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

This observational pilot prospective study will evaluate a new method for remote monitoring of corrected QT measurement using an artificial intelligence (AI)-based solution and ECG data collected via smartwatches (AI-QTc), in patients ambulatory treated with the HC-AZ combination, at the early stage of COVID-19 infection, at a tertiary hospital center. Daily ECGs will be performed via the smartwatches. AI-QTc will be compared to standard manual QTc reviewed by cardiologist. Correlation and agreement between measures will be assessed.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient over 18 years old * SARS-COV-2 confirmed infection by positive nasopharyngual PCR * Prescription of association hydroxychloroquine and azythromycine for COVI-19 therapy * Patient's smartphone able to download the smartwatches application

Exclusion criteria

* Presence of a pacemaker * Pregnant or breastfeeding females * Refusal to participate * Incapacity * Adult under legal protection (trusteeship, guardianship)

Design outcomes

Primary

Measure	Time frame	Description
Corrected QT (QTc) interval measurement	10 days	Measurement of QTc using an artificial intelligence (AI)-based solution and ECG data collected via smartwatches, compare to standard 12 leads ECG reviewed by cardiologist

Countries

France

Outcome results